Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy can produce symptoms that closely resemble a mild flu — fatigue, headache, body aches and nausea are among the most commonly reported early effects. These are real and can feel miserable in the first week or two, but they are typically a sign your body is adjusting rather than a sign something has gone wrong. Semaglutide (the active ingredient in Wegovy) is a prescription-only medicine, and how you experience it depends on factors a prescriber reviews before and during your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you take your first Wegovy pen on a Monday evening, and by Tuesday morning you feel wrung out. You're not running a temperature. You haven't been near anyone who's been ill. But you feel like you might be coming down with something — heavy limbs, a dull headache sitting just behind your eyes, an unsettled stomach, and a tiredness that won't shift with coffee. This is one of the most common early experiences people share when starting semaglutide.
What's happening is largely the result of GLP-1 receptor activation. Semaglutide slows the speed at which your stomach empties, which dampens appetite but also creates a background queasiness that can colour everything else. Add in the mild headache and fatigue that often accompany new GLP-1 treatment, and the overall picture sits close to a low-grade flu. The broader physical experience of Wegovy in those opening days is well documented by people who've been through it.
It is worth knowing that the 2.5mg starting dose exists partly to reduce this adjustment period. Some people sail through it; others feel rough for a few days after each early injection. Neither experience tells you whether the treatment will work well for you longer term.
The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, headache, dizziness and fatigue as common effects, particularly in early treatment and after dose increases. That cluster is what creates the flu impression. Actual influenza also brings fever, chills, and muscle aches that go beyond simple tiredness, so if you're running a genuine temperature or your joints feel like they've been in a vice, it is worth considering whether you have actually caught something.
Fatigue and headache, on their own, are well within the range of normal semaglutide adjustment. Many people find the weakness and low-energy feeling is most pronounced in the 24 to 48 hours after an injection, then gradually lifts. Some describe it as a kind of food-poisoning lite, you function, but you're not at your best. The NHS guidance on semaglutide confirms this gastrointestinal-led profile and notes that effects are typically most noticeable when starting treatment or moving up to a new dose.
One thing that is not a typical Wegovy symptom: feeling cold without explanation. If that's troubling you, a separate question worth exploring is whether semaglutide can cause cold sensitivity, as the mechanism differs from the flu-like picture described here.
Most of the time, the right answer is to be patient and practical. Eating smaller amounts, choosing plain foods, staying well hydrated, and giving your body a day or two after each new dose all help. The flu-like window is usually short. By week three or four on the same dose, the majority of people report that the worst has passed. A sensible approach to what you eat alongside treatment can also take some of the edge off how your gut responds.
There are situations where you should speak to a clinician rather than waiting it out. Severe or persistent stomach pain that radiates to your back needs same-day medical attention, the MHRA's January 2026 Drug Safety Update flagged acute pancreatitis as a known, if uncommon, side effect of GLP-1 medicines that requires urgent assessment. Equally, signs of significant dehydration from repeated vomiting or diarrhoea, or symptoms that feel far out of proportion to a normal adjustment period, are worth a call. You can report any unexpected effects directly at the MHRA's Yellow Card scheme.
If you're wondering whether to keep taking Wegovy while you actually have the flu, that's a different question with its own nuances around hydration and timing, our page on taking Wegovy when you're genuinely unwell covers exactly that.
Wegovy is a prescription-only medicine. Getting it through a service with real clinical oversight means you have someone to contact when things feel uncertain, not just at the consultation stage, but throughout. If the flu-like feeling is intense enough to affect your daily life, or if it keeps returning with every dose rather than fading over time, that pattern deserves a clinical conversation, not just reassurance from a forum.
Understanding the wider picture of what life on Wegovy involves (beyond just the early weeks) can also help you calibrate whether what you're experiencing is typical. Our semaglutide overview and the Wegovy treatment page cover the clinical background in full. For a broader look at your options, the weight-loss treatment overview is a useful starting point.
If you're considering starting treatment and want your questions answered by a real clinician before you commit to anything, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.